Phase I clinical trials in oncology

被引：0
|
作者：
Ganesan, Prasanth [1 ]
机构：
[1] JIPMER, Dept Med Oncol, Pondicherry, India
来源：
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2020年 / 41卷 / 06期
关键词：
D O I：
10.4103/ijmpo.ijmpo_7_20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：885 / 888
页数：4
相关论文
共 50 条
  • [31] Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
    Douma, Joeri A. J.
    Buffart, Laurien M.
    Sedhom, Ramy
    Labots, Mariette
    van der Houven van Oordt, Willemien C.
    Skardhamar, Mikkjal
    De Felice, Anthony
    Lee, Esther
    Dharmaraj, Divya
    Azad, Nilofer S.
    Carducci, Michael A.
    Verheul, Henk M. W.
    CANCERS, 2021, 13 (10)
  • [32] The changing landscape of phase I trials in oncology
    Kit Man Wong
    Anna Capasso
    S. Gail Eckhardt
    Nature Reviews Clinical Oncology, 2016, 13 : 106 - 117
  • [33] Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials
    Camidge, D. Ross
    Park, Haeseong
    Smoyer, Karen E.
    Jacobs, Ira
    Lee, Lauren J.
    Askerova, Zemfira
    McGinnis, Justin
    Zakharia, Yousef
    FUTURE ONCOLOGY, 2021, 17 (24) : 3271 - 3280
  • [34] Randomised Phase 1 clinical trials in oncology
    Iasonos, Alexia
    O'Quigley, John
    BRITISH JOURNAL OF CANCER, 2021, 125 (07) : 920 - 926
  • [35] Randomised Phase 1 clinical trials in oncology
    Alexia Iasonos
    John O’Quigley
    British Journal of Cancer, 2021, 125 : 920 - 926
  • [36] Evolution of early phase clinical trials in oncology
    Bui, Nam Q.
    Kummar, Shivaani
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (01): : 31 - 38
  • [37] Evolution of early phase clinical trials in oncology
    Nam Q. Bui
    Shivaani Kummar
    Journal of Molecular Medicine, 2018, 96 : 31 - 38
  • [38] Pleading for phase V clinical trials in oncology
    Gligorov, J.
    Debrix, I.
    Boelle, P. -Y.
    Flahault, A.
    ONCOLOGIE, 2008, 10 : S97 - S99
  • [39] Clinical benefits and risks of phase I oncology trials: experience from a single institution
    Gollamudi, R.
    Wong, B. M.
    Ghalib, M. H.
    Kumar, M.
    Desai, K.
    Chaudhary, I.
    Goel, S.
    Mani, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical Trials
    Coleman, Robert L.
    Beck, J. Thaddeus
    Baranda, Joaquina C.
    Jacobs, Ira
    Smoyer, Karen E.
    Lee, Lauren J.
    Askerova, Zemfira
    McGinnis, Justin
    Ganti, Apar Kishor
    ONCOLOGY, 2021, : 444 - 453
12345